)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Eris Lifesciences
Eris Lifesciences (ERIS) investor relations material
Eris Lifesciences Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary13 Feb, 2026
Executive summary
Q3 and nine-month results showed strong growth in branded formulations, international business, and consolidated operations, with record consolidated revenue of INR 807 crore in Q3, up 11% year-on-year, and adjusted PAT up 38.5% year-on-year.
International business achieved its highest-ever quarterly revenue, up 45% year-on-year, and EBITDA up 46%.
Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, were approved with unmodified auditor opinions.
The company operates primarily in the pharmaceuticals segment, with recent expansions and acquisitions impacting group structure.
Financial highlights
Branded Formulations Q3 revenue: INR 696 crore; nine months: INR 2,106 crore; EBITDA for Q3: INR 254 crore; nine months: INR 781 crore.
International business Q3 revenue: INR 111 crore (45% growth); nine months: INR 259 crore (11% growth); Q3 EBITDA margin: 30%.
Consolidated Q3 revenue: INR 807 crore (11% growth); nine months: INR 2,373 crore; Q3 operating profit: INR 282 crore (13% growth); Q3 EPS: INR 9.
Consolidated net profit for the quarter was INR 108.83 crore, and for nine months, INR 368.40 crore.
Exceptional item of INR 17 crore in Q3 due to new labour code, increasing employee-related liabilities.
Outlook and guidance
Branded Formulations expected to close the year with 13%-14% growth and EBITDA margin above 39% (excluding discontinued brands).
Full-year consolidated revenue guidance: INR 3,200 crore (12% growth, excluding trade generics); EBITDA guidance: INR 1,150 crore (15% growth).
FY 2027 projected as a breakout year for international business, with revenue of INR 550-600 crore and EBITDA of INR 180-200 crore.
Net debt to EBITDA ratio targeted at 1.5x by year-end.
The company completed the acquisition of the remaining 30% stake in Swiss Parenterals Limited, making it a wholly owned subsidiary as of January 16, 2026.
New Labour Codes: Ongoing cost implications?
Swiss Parenterals full acquisition: Key benefits?
ETL, AHL, EOHPL scheme: What are the goals?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Eris Lifesciences earnings date
Q4 25/2619 May, 2026
Eris Lifesciences
Next Eris Lifesciences earnings date
Q4 25/2619 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Eris Lifesciences Limited is an India-based pharmaceutical company engaged in the development, manufacturing, and marketing of branded formulations. The company focuses on therapeutic areas such as cardiovascular, diabetes, neurology, gastroenterology, and dermatology. It primarily caters to the domestic market, targeting healthcare professionals and patients through its portfolio of prescription medicines. The company is headquartered in Ahmedabad, India, and its shares are listed on the NSE and BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage